tiprankstipranks
Vireo Growth (VREOD)
OTHER OTC:VREOD
US Market
VREOD
Vireo Growth
RESEARCH TOOLSreports

Vireo Growth (VREOD) Stock Forecast & Price Target

103 Followers
See the Price Targets and Ratings of:

VREOD Financial Forecast

VREOD Earnings Forecast

Next quarter’s earnings estimate for VREOD is $0.17 with a range of $0.04 to $0.30. The previous quarter’s EPS was -$0.39. VREOD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year VREOD has Performed in-line its overall industry.
Next quarter’s earnings estimate for VREOD is $0.17 with a range of $0.04 to $0.30. The previous quarter’s EPS was -$0.39. VREOD beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year VREOD has Performed in-line its overall industry.

VREOD Sales Forecast

Next quarter’s sales forecast for VREOD is $167.36M with a range of $135.91M to $198.80M. The previous quarter’s sales results were $102.45M. VREOD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year VREOD has Performed in-line its overall industry.
Next quarter’s sales forecast for VREOD is $167.36M with a range of $135.91M to $198.80M. The previous quarter’s sales results were $102.45M. VREOD beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year VREOD has Performed in-line its overall industry.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
TRAXFirst Tracks Biotherapeutics Inc
EVMNEvommune, Inc.
MPLTMapLight Therapeutics, Inc.
MAZEMaze Therapeutics, Inc.
AAPGAscentage Pharma Group International Unsponsored ADR
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

VREOD Analyst Recommendation Trends

Rating
Aug 23
Apr 24
Aug 24
Nov 24
Mar 25
Strong Buy
0
0
0
0
0
Buy
0
0
0
0
0
Hold
3
3
3
3
3
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
3
3
3
3
3
In the current month, VREOD has received 0 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. VREOD average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.

VREOD Stock Forecast FAQ

What is VREOD’s average 12-month price target, according to analysts?
Currently, no data Available
What is VREOD’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for VREOD, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is VREOD a Buy, Sell or Hold?
      Vireo Growth has a consensus rating of Hold which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
        What is Vireo Growth’s price target?
        Currently, no data Available
        What do analysts say about Vireo Growth?
        Vireo Growth’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
          How can I buy shares of VREOD?
          Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.